Skip to content
Navigate to homepage - Cerba Research

Case Study – Phase 1 Dose Escalation Study With A Bispecific Antibody In Relapse Refractory Multiple Myeloma (RRMM)

Discover how we manage routine and specialty test for a Phase 1 study.

Cerba US Expansion Tour VF.00_04_27_19.Still010

Reach out to our experts and discover how we can help you advance your clinical trial

Contact Us